ArticleMolecular cancer therapeutics2023

Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E-based Antibody-Drug Conjugate for Treatment of Nectin-4-expressing Cancers.

Wei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.